(VIANEWS) – MakeMyTrip Limited (MMYT), Meta Platforms (META), MiMedx Group (MDXG) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. MakeMyTrip Limited (MMYT)
29.7% sales growth and 5.58% return on equity
MakeMyTrip Limited, an online travel company, sells travel products and solutions in India, the United States, Singapore, Malaysia, Thailand, the United Arab Emirates, Peru, Colombia, and Indonesia. The company operates through three segments: Air Ticketing, Hotels and Packages, and Bus Ticketing. Its services and products include air tickets; hotels; packages; rail tickets; bus tickets; and car hire, as well as ancillary travel requirements, such as visa processing and facilitating access to travel insurance. The company allows travelers to research, plan, book, and purchase travel services and products through its Websites makemytrip.com, goibibo.com, redbus.in, makemytrip.com.sg, and makemytrip.ae; and other technology-enhanced distribution channels, such as call centers, travel stores, and travel agents' network, as well as mobile service platform. As of March 31, 2021, it had approximately 150 franchisee-owned travel stores. The company serves leisure and corporate travelers. MakeMyTrip Limited was incorporated in 2000 and is based in Gurugram, India.
Earnings Per Share
As for profitability, MakeMyTrip Limited has a trailing twelve months EPS of $0.46.
PE Ratio
MakeMyTrip Limited has a trailing twelve months price to earnings ratio of 149.41. Meaning, the purchaser of the share is investing $149.41 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.58%.
Sales Growth
MakeMyTrip Limited’s sales growth is 37.6% for the present quarter and 29.7% for the next.
Moving Average
MakeMyTrip Limited’s worth is way above its 50-day moving average of $57.44 and way higher than its 200-day moving average of $42.48.
2. Meta Platforms (META)
25.6% sales growth and 28.04% return on equity
Meta Platforms, Inc. engages in the development of products that enable people to connect and share with friends and family through mobile devices, personal computers, virtual reality headsets, and wearables worldwide. It operates in two segments, Family of Apps and Reality Labs. The Family of Apps segment offers Facebook, which enables people to share, discuss, discover, and connect with interests; Instagram, a community for sharing photos, videos, and private messages, as well as feed, stories, reels, video, live, and shops; Messenger, a messaging application for people to connect with friends, family, communities, and businesses across platforms and devices through text, audio, and video calls; and WhatsApp, a messaging application that is used by people and businesses to communicate and transact privately. The Reality Labs segment provides augmented and virtual reality related products comprising consumer hardware, software, and content that help people feel connected, anytime, and anywhere. The company was formerly known as Facebook, Inc. and changed its name to Meta Platforms, Inc. in October 2021. The company was incorporated in 2004 and is headquartered in Menlo Park, California
Earnings Per Share
As for profitability, Meta Platforms has a trailing twelve months EPS of $14.87.
PE Ratio
Meta Platforms has a trailing twelve months price to earnings ratio of 34.76. Meaning, the purchaser of the share is investing $34.76 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.04%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 24.7%, now sitting on 134.9B for the twelve trailing months.
Moving Average
Meta Platforms’s worth is way higher than its 50-day moving average of $426.63 and way above its 200-day moving average of $335.58.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Meta Platforms’s EBITDA is 9.35.
Previous days news about Meta Platforms(META)
- According to FXStreet on Monday, 8 April, "Analysis and Trading Strategies Using Elliott Wave Theory on NASDAQ Stock Market: Focusing on NASDAQ 100, S&P 500, and Key Stocks Including Apple (AAPL), Tesla (TSLA), Amazon (AMZN), Nvidia (NVDA), Microsoft (MSFT), Meta Platforms (META), Netflix (NFLX), and Alphabet (GOOGL)."
3. MiMedx Group (MDXG)
9.5% sales growth and 62.09% return on equity
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a semi-permeable protective barrier membrane product used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, pressure ulcers, and burns; AmnioFix, a semi-permeable protective barrier membrane product for the treatment of wounds related to surgical procedures; EpiCord and AmnioCord that are dehydrated human umbilical cord allografts intended for homologous applications; and AmnioFill that consists of particles of connective tissue matrix derived from placental disc and placental membranes. The company's products have applications primarily in the areas of wound care, burn, surgical, and non-operative sports medicine sectors of healthcare. It also sells allografts for dental applications on an original equipment manufacturer basis. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. is headquartered in Marietta, Georgia.
Earnings Per Share
As for profitability, MiMedx Group has a trailing twelve months EPS of $0.43.
PE Ratio
MiMedx Group has a trailing twelve months price to earnings ratio of 18.7. Meaning, the purchaser of the share is investing $18.7 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 62.09%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
MiMedx Group’s EBITDA is 3.57.
Revenue Growth
Year-on-year quarterly revenue growth grew by 16.7%, now sitting on 321.48M for the twelve trailing months.
Yearly Top and Bottom Value
MiMedx Group’s stock is valued at $8.04 at 06:22 EST, way below its 52-week high of $9.27 and way above its 52-week low of $3.08.
Moving Average
MiMedx Group’s value is under its 50-day moving average of $8.08 and higher than its 200-day moving average of $7.47.
4. Garmin (GRMN)
9.2% sales growth and 19.52% return on equity
Garmin Ltd. designs, develops, manufactures, markets, and distributes a range of wireless devices worldwide. Its Fitness segment offers running and multi-sport watches; cycling products; smartwatch devices; scales and monitors; and fitness accessories. This segment also provides Garmin Connect and Garmin Connect Mobile, which are web and mobile platforms where users can track and analyze their fitness, activities and workouts, and wellness data; and Connect IQ, an application development platform. The company's Outdoor segment offers adventure watches, outdoor handhelds and satellite communicators, golf devices, consumer automotive devices, and dog devices, as well as InReach and Gramin response communication device. Its Aviation segment designs, manufactures, and markets various aircraft avionics solutions, including integrated flight decks, electronic flight displays and instrumentation, navigation and communication products, automatic flight control systems and safety-enhancing technologies, audio control systems, engine indication systems, traffic awareness and avoidance solutions, ADS-B and transponders, weather information and avoidance solutions, datalink and connectivity solutions, and various services. The company's Marine segment provides chartplotters and multi-function displays, cartography products, fishfinders, sonar products, autopilot systems, radars, compliant instrument displays and sensors, VHF communication radios, handhelds and wearable devices, sailing products, audio products and accessories, digital switching products, and trolling motors. Its Auto segment offers embedded domain controllers and infotainment units; and software, map database, cameras, wearables, and automotive solutions. The company sells its products through independent retailers, dealers, distributors, installation and repair shops, and original equipment manufacturers, as well as online webshop. Garmin Ltd. was founded in 1989 and is based in Schaffhausen, Switzerland.
Earnings Per Share
As for profitability, Garmin has a trailing twelve months EPS of $6.71.
PE Ratio
Garmin has a trailing twelve months price to earnings ratio of 22.11. Meaning, the purchaser of the share is investing $22.11 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.52%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Mar 14, 2024, the estimated forward annual dividend rate is 3 and the estimated forward annual dividend yield is 2.11%.
Volume
Today’s last reported volume for Garmin is 418284 which is 56.44% below its average volume of 960314.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Garmin’s EBITDA is 4.85.
